Published date: 2 October 2018
Last edited date: 2 October 2018
Awarded contract - This means that the contract has been awarded to a supplier.
Contract summary
Industry
Administrative healthcare services - 75122000
Location of contract
Any region
Value of contract
£0
Procurement reference
tender_174218/699419
Published date
2 October 2018
Closing date
13 July 2018
Contract start date
7 August 2018
Contract end date
8 February 2019
Contract type
Service contract
Procedure type
Other: Sub OJEU
Contract is suitable for SMEs?
Yes
Contract is suitable for VCSEs?
No
Description
As part of the review of evidence on dependence, and the short term discontinuation or longer term withdrawal symptoms associated with prescribed medicines, PHE wishes to commission an external partner to undertake a Rapid Evidence Assessment (REA) which includes a call for papers, and to synthesise the findings into one report that:
a) Describes the harms associated with dependence, and the short term discontinuation and longer term withdrawal symptoms from the following prescribed medicines: opioids for chronic pain (excluding end of life /palliative care/cancer pain), benzodiazepines, Z-drugs, gabapentin and pregabalin (excluding epilepsy treatment), and antidepressants
b) Describes the factors that contribute to the risk of harms associated with dependence and and the short term discontinuation or longer term withdrawal symptoms from the medicines listed in the review.
c) Identifies effective and cost effective approaches to the prevention and treatment of dependence and and the short term discontinuation or longer term withdrawal symptoms from the medicines listed in the review.
d) Summarises evidence about patients' own experiences of the harms caused by prescribed medicines specifically relating to dependence and and the short term discontinuation or longer term withdrawal symptoms from the medicines listed in the review.
e) Identifies and describes existing examples of best practice (e.g. services providing withdrawal support) and evaluates the effectiveness and cost effectiveness of the UK health/social service delivery models that prevent or treat dependence and the short term discontinuation or longer term withdrawal symptoms associated with the medicines listed in the review (as well as health service delivery models in other countries that might inform UK provision).
Award information
Awarded date
3 August 2018
Contract start date
7 August 2018
Contract end date
8 February 2019
Total value of contract
£95,680
This contract was awarded to 1 supplier.
Royal College of Physicians
Address
11 St Andrews Place, Regents Park, London, ALTRO, NW1 4LE, UNITED KINGDOM
Reference
None
Supplier is SME?
No
Supplier is VCSE?
No
About the buyer
Contact name
Tim Purchase
Address
Salisbury
Salisbury
SP4 0JG
England
Telephone
01980 612648
Share this notice
Closing: 13 July 2018
All content is available under the
